Avideh Nazeri, Vice President of Clinical, Medical and Regulatory for Novo Nordisk UK, reflects on her journey through the ...

Disrupting F-actin in aged brains restored brain autophagy to youthful levels and reversed some cellular markers of brain ageing. Researchers at UCLA have been able to prevent filamentous actin ...

The findings offer a promising drug target to prevent progression to colon cancer by targeting abnormal cells early on. The role of the p53 gene in the pathogenesis of ulcerative colitis (UC) has been ...

Anirban Datta, Head of Discovery Biology at Verseon International Corporation, details how recent breakthroughs are bringing once-distant possibilities, such as testing drugs more efficiently and ...

Listen to this episode to discover how microbiomics is being leveraged to translate gut microbiome findings into new therapeutic options. In this episode, titled ‘Leveraging “omics” for novel ...

Therapeutic antibodies play a key role in addressing unmet medical needs. Here, Dr Judy Chou, CEO, President and Board Member of AltruBio, Inc, explains how agonist antibodies show potential as a ...

Small molecules are essential for developing effective medicines, but their structural complexity and material behaviour present difficulties. In this article, Chris Brown, Senior Chemist, Onyx ...

Researchers have uncovered a how INPP4B, alongside PIKfyve and TRPML-1, drives pancreatic cancer metastasis. Researchers at the University of Toronto, Toronto Metropolitan University and the Princess ...

Søren Bregenholt, Chief Executive Officer at Alligator Bioscience, elucidates how creating bispecific antibodies that target both tumour-specific antigens and CD40, a receptor on the immune system’s ...

We had the privilege of talking to Veerle d’Haenens, General Manager, Global Therapy Innovations at Terumo Blood and Cell Technologies. Her successful career has been driven by her creativity, ...